1. Home
  2. IVVD vs USNA Comparison

IVVD vs USNA Comparison

Compare IVVD & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.55

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$21.67

Market Cap

382.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
USNA
Founded
2020
1992
Country
United States
United States
Employees
100
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.1M
382.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
IVVD
USNA
Price
$1.55
$21.67
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$8.75
$36.00
AVG Volume (30 Days)
2.6M
100.7K
Earning Date
04-11-2026
05-17-2026
Dividend Yield
N/A
N/A
EPS Growth
20.99
N/A
EPS
N/A
0.67
Revenue
$25,384,000.00
$1,060,902,000.00
Revenue This Year
$107.86
$5.41
Revenue Next Year
$146.53
$6.12
P/E Ratio
N/A
$32.34
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$18.48
52 Week High
$3.07
$38.32

Technical Indicators

Market Signals
Indicator
IVVD
USNA
Relative Strength Index (RSI) 37.24 49.35
Support Level $1.50 $18.57
Resistance Level $1.66 $22.52
Average True Range (ATR) 0.15 1.13
MACD 0.01 -0.15
Stochastic Oscillator 25.35 56.46

Price Performance

Historical Comparison
IVVD
USNA

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Share on Social Networks: